GGrantIndex
Sort

1,049,261 grants matching t cell

Liver Cancer Program

$2,440,951
Anuradha Budhu · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA

Polymerase theta, genome instability, and cancer

$2,440,899
Dale A Ramsden · Univ Of North Carolina Chapel Hill · P01 · FY2025 · CA

Center for multidimensional atlas of the human heart

$2,440,764
Kai Tan · Children'S Hosp Of Philadelphia · U54 · FY2024 · HL

Targeting mTOR and CD40 Pathways for Adjuvanting HIV Vaccines

$2,440,751
Rama Rao Amara · Emory University · P01 · FY2010 · AI

THE THERAPY OF AML

$2,440,745
Michael W Andreeff · University Of Tx Md Anderson Can Ctr · P01 · FY2009 · CA

DEVELOPMENT OF A LOW-COST SINGLE CRYSTAL SILICON SUBSTRATE PROCESS FOR >23% SOLAR CELLS

$2,440,577
Leading Edge Equipment Te · · FY2021 · Department of Energy

Maternal and infant immunization to eliminate breast milk transmission of HIV-1

$2,440,281
Sallie R. Permar · Duke University · P01 · FY2015 · AI

Development of a Potent and Highly Selective NaV1.7 Inhibitor for the Treatment of Acute Pain with the Goal of Reducing Opioid Use and Preventing Opioid Use Disorders

$2,440,102
John Cureton Hunter · Siteone Therapeutics, Inc. · UG3 · FY2020 · DA

Notch-Mediated Expansion of Cord Blood Progenitors for Stem Cell Transplant

$2,440,031
Colleen Delaney · Fred Hutchinson Cancer Research Center · P50 · FY2017 · HL

Cancer Center Support Grant (CCSG)

$2,440,011
George J Weiner · University Of Iowa · P30 · FY2016 · CA

Nanoscale approaches to allelic silencing in myocardial disease states

$2,439,872
Euan A Ashley · Stanford University · DP2 · FY2009 · OD

ZZ-3K3A-201: Safety evaluation of 3K3A-APC in ischemic stroke

$2,439,849
Patrick D Lyden · Cedars-Sinai Medical Center · U01 · FY2014 · NS

MEMORIAL SLOAN-KETTERING CANCER GENE THERAPY PROGRAM

$2,439,650
Sloan-Kettering Institute For Cancer Res · P01 · FY2004 · CA

Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Moderate to Severe Flares: A Phase 3 Multi-Center, Randomized, Double-Blind, Sham-Controlled Trial

$2,439,584
Parambir Singh Dulai · Northwestern University At Chicago · U01 · FY2023 · DK

Superfund Research Center: Developmental Toxicants: Mechanisms, Consequences and

$2,439,555
Richard Di Giulio · Duke University · P42 · FY2015 · ES

Studies of Physiologic and Pathologic Platelet Plug Formation

$2,439,527
Lawrence F Brass · University Of Pennsylvania · P01 · FY2023 · HL

Physics of collective cellular migration in lung health and disease

$2,439,449
Jeffrey J Fredberg · Harvard School Of Public Health · P01 · FY2016 · HL

Comparative Genomics of Longevity

$2,439,250
Vera Gorbunova · University Of Rochester · P01 · FY2019 · AG

Vascular Contributions to Dementia and Genetic Risk Factors for Alzheimer's Disease

$2,439,205
Berislav V Zlokovic · University Of Southern California · P01 · FY2017 · AG

WEILL CORNELL PROGRAM OF EXCELLENCE IN GENE THERAPY

$2,439,199
Weill Medical College Of Cornell Univ · U01 · FY2002 · HL

Exploring the biology of persistent type 2 airway niches in asthma

$2,438,988
John V Fahy · University Of California, San Francisco · P01 · FY2023 · HL

Exploring the biology of persistent type 2 airway niches in asthma

$2,438,988
John V Fahy · University Of California, San Francisco · P01 · FY2021 · HL

Exploring the biology of persistent type 2 airway niches in asthma

$2,438,988
John V Fahy · University Of California, San Francisco · P01 · FY2022 · HL

Exploring the biology of persistent type 2 airway niches in asthma

$2,438,988
John V Fahy · University Of California, San Francisco · P01 · FY2020 · HL

University of New Mexico (UNM) Center for Brain Recovery and Repair

$2,438,975
Claude W Shuttleworth · University Of New Mexico Health Scis Ctr · P20 · FY2015 · GM